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Abstract  
 
Diabetes prevalence is growing at an alarming rate. This will cause increases of 
comorbidities including blindness, kidney failure, and limb amputation in diabetic subjects if left 
untreated. Dietary interventions such as limiting sugars and saturated fats greatly improve the 
management of the disease. Excess glucose from the diet is stored as glycogen in the liver or 
muscle through glycogenesis, which is promoted by insulin. Patients with diabetes do not 
properly create or do not properly respond to insulin, leading to a decrease of glycogenesis and 
increase in glucose in the blood stream. As a micronutrient, vitamin A has been shown to affect 
the glucose and lipid metabolism. Recent studies have begun to investigate the role of vitamin A 
in combination with insulin as a potential regulator in control of glucose metabolism and 
glycogenesis. The current study is aimed to investigate glycogenesis in the presence of the active 
form of retinoic acid (RA) without or with insulin. Rat HL1C hepatoma cells were treated with 
control (vesicle control), 10 µM RA, 10 nM insulin, and 10 nM Insulin + 10 µM RA for 48 
hours. After that, the glycogen content in those cells was determined using a glucose release 
assay to evaluate the effects of RA and insulin on glycogenesis in HL1C cells. The results show 
that RA did not increase the glycogen content by itself or in the presence of insulin in HL1C 
cells. We conclude that RA does not affect the insulin-induced glycogenesis in hepatoma cells. 
This may be helpful to evaluate vitamin A’s effects on diabetes development for patient in the 
diabetic community.    
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Introduction 
According to the World Health Organization (WHO), obesity in recent years has become 
a global epidemic affected young children to older adults 1. Obesity is not a malnutrition problem 
isolated to high-income countries. Except for in Africa and Asia, there are more people 
worldwide who are obese than who are underweight. In 2017, it was estimated that around 4 
million people worldwide died of obesity or of obesity related health issues 1. An individual is 
classified as being obese if his/her body mass index (BMI) is over 30 kg/m2 and is classified as 
overweight if the BMI is over 25 kg/m2 1. Obesity is associated with several comorbidities 
including cardiovascular disease, stroke, and diabetes. There is also a link to several cancers, 
such as breast, prostrate, liver, kidney, and colon cancers specifically 1. The rise in obesity has 
played a role in the rise of these comorbidities, which has led to elevated health care costs in 
obese individuals. Obesity carries with it a vast amount of other health problems, making it an 
issue that needs to be addressed in order to save the lives of people worldwide.  
The association between certain vitamins and minerals and obesity has been a growing 
field of interest for researchers around the world. Vitamin A (retinol) and its active form retinoic 
acid (RA) have been studied in the context of obesity, insulin resistance, type 2 diabetes in 
efforts to find new biochemical bridges between the two elements. As a micronutrient, vitamin A 
is essential, meaning that it cannot be synthesized in the body. One important source of an 
individual’s vitamin A comes from carotenoids, which are phytochemicals in colorful and leafy 
plants and vegetables 2. Carotenes are a class of carotenoids including the specific chemical beta-
carotene. Beta-carotene is also referred to as pro-vitamin A because it can be converted to retinal 
then retinol after reduction 2. Vitamin A exists as retinyl esters in meat-based foods, such as liver 
and fish 2. Both beta-carotene and retinyl esters are metabolized to retinol 3. Retinol undergoes a 
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two-step conversion to become RA. Retinol is oxidized to retinaldehyde by alcohol 
dehydrogenases and retinol dehydrogenase. Retinaldehyde is then further oxidized to RA by 
retinaldehyde dehydrogenase 3.  
RA’s effects on an individual’s physiology is primarily due to its ability to regulate 
transcription of its targeted genes 4. RA is a ligand that binds to retinoic acid receptor (RAR) 4, 
and retinoid X receptor (RXR)4, which form an RAR/RXR heterodimer or RXR/RXR 
homodimer. The activation of RAR and RXR by RA causes changes in transcription 4. These 
dimers bind to retinoid acid responsive elements (RARE’s) which are present on DNA sequences 
of promoters of target genes regulated by RA 4. There are a large number of genes that contain 
RARE sequences, making them responsive toward RA levels in the body. These include genes 
coding for embryonic development, neural differentiation, structural proteins, enzymes, 
receptors, hormones, growth factors, and cytokines 4.  
In order to understand the role of vitamin A and its interactions with glycogenesis, it is 
first important to gain an understanding of the liver’s role in glycogenesis and glucose usage. 
Glucose is stored as glycogen in animal cells with the largest amount being held in muscle and 
liver cells 5. The liver usually contains about 4-7% of its weight as glycogen 5. The liver is much 
more complex than the muscle in maintaining glucose levels and its own metabolic energy 
needs. It is responsible for maintaining blood glucose levels during short fasting periods while 
also integrating the supply of available fuels with metabolic needs of other tissues 5. Under the 
correct physiological conditions, the liver can provide glucose for the whole body 5. The liver 
can generate and release glucose to target tissues through gluconeogenesis (the synthesis of 
glucose from non-carbohydrate sources) and from glycogenolysis (the breakdown of stored 
glycogen) 5. Since the liver is involved in providing glucose to other tissues as well as itself, the 
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rate of glycogenesis is controlled and affected by a number of different physiological conditions 
in the body.  
Glycogenesis is the metabolic pathway in which glucose is stored as glycogen in cells. 
Excess glucose must be stored in the body for later use. In the liver, glycogen is mainly used for 
blood glucose homeostasis 6. Before glucose is stored as glycogen, a series of reactions must take 
place to convert glucose to stored glycogen. Glycogenesis begins with the phosphorylation of 
glucose by glucokinase and hexokinases to create glucose-6-phosphate 5. Glucose-6-phosphate is 
then converted to glucose-1-phosphate by phosphoglucomutase 5. Glucose-1-phosphate is next 
converted to uridine diphosphate glucose (UDP glucose) by UDP-glucose phosphorylase with 
the cofactor uridine trisphosphate 5. The resulting UDP glucose is the precursor to glycogen 
synthesis 5.  
 UDP glucose is attached to a tyrosyl residue on the glycogenin protein 5. Glycogenin 
initiates the genesis and growth of a chain of glycogen as more UDP glucose is added 5. The 
UDP glucose is added to the growing chain by the enzyme glycogen synthase 5. Once attached to 
the chain, UDP glucose is referred to as glucan. The chain continues to grow by autocatalysis 5. 
Soon branching off of the growing chain begins to occur. On the growing chain, the fourth 
glucan subunit binds to the first glucan of a chain of 6 glucans bonded in an alpha 1-6 
configuration 5. This is an alpha 1-4 to alpha 1-6 bond facilitated by a branching enzyme 5. This 
continues to occur in a rosette-like pattern radiating out from the glycogenin base to form a 
spherical shape 5. The activation of the insulin signaling pathway signals for glycogenesis to 
begin in the liver 6.   
Glycogen breakdown (glycogenolysis) or glycogen synthase (glycogenesis) have been 
shown to be linked to individual enzymes and key regulators of both pathways as well as vitamin 
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A. Investigation into this field began as early as the 1930’s. A study in the 1960’s investigated 
the pathways of glycogen in the body. Singh, Singh, and Dileepan looked at the role of vitamin 
A toxicity in the hepatic glycolysis pathway in rats 8. They found that vitamin A toxicity caused 
an enlargement of the liver, as well as an increase in the levels of lipids, glycogen and vitamin A 
in the liver 8. The study also concluded that vitamin A increases the activity of key 
gluconeogenic enzymes but did not do the same for glycolysis.  
Diabetes exists in two types; type 1 or type 2. Type 1 diabetes mellitus (T1DM) is usually 
first diagnosed in childhood and results in insulin dependence 8. T1DM patients produce little to 
no insulin on their own 8. Type 2 diabetes mellitus (T2DM) is the most common form of diabetes 
8. T2DM results from the body’s resistance to insulin, typically as a result of overproduction and 
hypersecretion of insulin due to chronic consumption of high sugary or high fat foods. Insulin is 
an endocrine hormone in the body because it activates a signaling cascade which leads to the 
cell’s uptake and use of blood glucose (glucose molecules in the blood stream) among many 
other physiological functions 9. Serious health consequences can occur in those with either 
T1DM or T2DM if their insulin levels are not carefully monitored. People with diabetes can 
increase the overall risk of a premature death as well as cause serious damages to the heart, blood 
vessels, eyes, kidneys, and nerves 8.  
Studies looking more closely at the relationship between vitamin A and insulin have 
proven to be promising fields in the future of nutrition related research. Studies from Dr. Guoxun 
Chen’s lab in the Department of Nutrition at the University of Tennessee made headway to 
investigate the relationship between the insulin signaling pathway and vitamin A. In a study 
designed to find how vitamin A status affects obesity, Zhang et al 10 showed that the sterol 
regulatory element binding protein 1c gene (Srebp-1c ) gene in the liver was significantly lower 
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in vitamin A deficient lean and fatty rats as compared to vitamin A sufficient rats 10. Srebp-1c is 
a lipogenic gene, meaning it functions in the creation of fats for storage 10. It can be expressed as 
a result of insulin-induced lipogenesis in the liver. The liver X receptor elements on the hepatic 
Srebp-1c promoter responsible for insulin response are also retinoic acid receptor elements 
(RARE’s) 9. It is interesting to note that the hepatic Srebp-1c expression level in vitamin A 
deficient rats is significantly lower than that in vitamin A sufficient rats. 
Additionally, the expression level of hepatic expression of Gck (glucose kinase gene) and 
Pklr (liver type pyruvate kinase gene) mRNA are significantly lower in vitamin A deficient rats 
than in vitamin A sufficient rats 10. This suggests a relationship between vitamin A status and 
glycolysis. It suggests that decreasing the amount of vitamin A in the diet leads to a decrease in 
the enzymes needed for glycolysis. A recent study in 2018 provided the momentum for the 
construction of this thesis. Dr. Chen and other researchers investigated the role of vitamin A’s 
effects on metabolic abnormalities in rats fed a high fat-diet. The research results indicated that 
vitamin A status altered the expression of levels of proteins required for glucose metabolism 9. 
Dr. Chen et al. 9 concluded that vitamin A status contributes to the regulation of hepatic glucose 
metabolism and could regulate hepatic carbohydrate metabolism.  
The interconnection between vitamin A status and hepatic carbohydrate metabolism is 
complex upon peering into the depths of the current literature. It is for this reason, and under the 
guidance of Dr. Chen, that this study was constructed. The goal of this thesis is to investigate 
further the interconnection between RA and insulin in liver cells with hopes to find data 
indicating promising areas of research moving forward. In order to implement this research into 
a two-semester time frame, the study was focused on the effects of RA and insulin on 
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glycogenesis in HL1C hepatoma cells. Based off of the current literature, it is Dr. Chen’s 
hypothesis that an interaction exists between RA and insulin in glycogenesis in hepatoma cells.  
 
  
 9 
Materials and Methods  
Treatment Groups 
Four different treatment groups were created for this experiment. The groups were 
control (vesicle control), 10 µM RA, 10 nM Insulin, and Insulin + 10 µM RA. Fourteen plates 
were subcultured for each round of experiments. Of the 14 plates used, 12 were treated with 
different media corresponding to the different control and test groups while the remaining 2 were 
used to continue the cell line via subculture. These 2 plates underwent a 1 plate to 7 plate 
subculture, resulting in 14 plates for more rounds of the experiment. The 12 plates were divided 
evenly into 4 groups of 3 plates. Of the 3 plates in each group, 2 were used to assess glycogen 
content and the remaining plate was used for protein analysis. Prior to treatment, the medium of 
the cells was switched from containing 5% FBS to contain 0.5% FBS. After two days of 
incubation with the treatment media, the plates were removed for analysis. This process was 
repeated two additional times for a total of 3 experimental rounds.  
Cell culture 
The tissues used for this experiment were obtained from the same lineage as outlined in a 
previous study by Dr. Chen and Dr. Meredith Howell 11. The DMEM medium used for cell 
growth was supplemented with 5% FBS and 1% PS. Beginning with 2 cell plates, the cells were 
subcultured upon reaching 70-80% confluence on the plate. Cells were allowed to reach the 
appropriate confluence in an incubator at 37 degrees Celsius with 5% CO2.   
Appropriate subculturing procedure followed the same standard procedure for each 
subculture. The cells were removed from the incubator and placed inside the fume hood to 
minimize the risk of contamination. All materials (pipets, new plates, media) was either 
autoclaved or sterilized with ethanol spray prior to entering the hood. The media were extracted 
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from the plates via pipet suction and discarded. The cells were incubated within 1 milliliter of 
trypsin solution for 2-3 minutes to detach them from the bottom of the plate and from each other. 
The duration of the trypsin wash varied by each subculture and each plate’s individual 
confluence level. After the removal of trypsin, the plates were washed with media to mix the 
cells with the media. The cells and media from the plate were then placed in the same tube to 
assure even displacement of the cells throughout the medium. This ensured that the same number 
of cells was inoculated onto each subculture plate. Three mL of medium containing cells were 
seeded into each plate and placed in the incubator for five days.  
Glycogen extraction 
 The plates were placed on ice and had their media vacuumed out. Four hundred 
microliters of ice-cold PBS were added to each plate. The plate was scrapped, and the content 
was transferred in a 1.5 microcentrifuge tube. The tube was centrifuged at 1,000 x RPM at 4 
degrees Celsius for 5 minutes. Residual liquid was removed as much as possible, and the 
remaining mass of cells was then weighed. 30% KOH solution was added to reach 10x the 
volume derived from the cell mass. This meant that if the average cell mass of all the tubes was 
40 mg, then 400 mL of 30% KOH was added to the tubes. The tubes were then placed in a 100 
degrees Celsius water bath for 30 minutes. Once removed, ice cold ethanol was added to equal 
60% of the final volume of the precipitate previously recorded. The tubes were next centrifuged 
for 15 minutes at 4 degrees Celsius at 19,000 RPM. The supernatant was then removed, and the 
remaining precipitate containing extracted glycogen was resuspended in 70 microliters of double 
distilled water and placed in the -80 degrees Celsius freezer until being used later.  
 When resuming and after thawing the tubes, 37 % HCl was added to each of the test 
tubes to equal to 3M final concentration. The tubes were next placed in a 100 degrees Celsius 
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water bath for 2 hours for hydrolysis of the glycogen to glucose. After this, the glucose 
concentration was measured using a glucose assay kit.  
Glucose liquicolor kit 
Four additional empty 1.5 mL tubes were used to serve as controls for the liquicolor kit. They 
were a hydrolysis glycogen control, a hydrolysis negative control, a glucose standard with 100 
microliters of glucose, and a negative kit control tube. Seven hundred microliters of the glucose 
reagent provided in the kit was added to each empty tube corresponding to each of the 
experimental group. Seven microliters of the sample of one tube was then added to the 
corresponding tube containing the 700 microliters of the glucose reagent. This was repeated for 
each of the tubes. A 96-well plate was then loaded with the samples and the controls for 
absorbance reading in the Glomax machine. The optical density each plate was recorded and 
corresponded to the amount of glucose present in the plate. The data were compiled into tables 
and graphs for statistical analysis.  
Statistical Analysis 
A full table of results containing numerical data can be found at the end of this report (Figure 2). 
All data were analyzed using ANOVA statistical analysis. The difference between data sets was 
considered statistically significant at p< 0.05.  
Results  
HL1C Cells treated with 10 nM Insulin and 10 nM Insulin + 10 µM RA released more total 
glucose from glycogen 
 As shown in Figure 1, a significantly greater amount of glucose was released from 
glycogen in the cells treated with10 nM Insulin, or 10 nM Insulin + 10 µM RA as compared to 
that from the control group. The glucose released from the 10 µM RA group was not significant 
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from that of the control group. Although there was no significant difference between the control 
and 10 µM RA group, there was still a trend of increase of glucose released from glycogen in 
cells in the 10 µM RA group than that in the control group. There was not a significant 
difference in total glucose released between the 10 µM RA and the 10 nM Insulin + 10 µM RA 
group, even though there seems to be a trend that the amount of glucose released was greater in 
the 10 nM Ins. + 10 µM RA group.  
 
Figure 1 shows the data collected from the total glucose released from HL1C cells treated with 
the control, RA, insulin, and Insulin + RA groups for 48 hours.  
 
Figure 1. Total Glucose Released 
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will be a correlation between the amount of glucose released and the amount of glycogen which 
was initially stored in the cells. This logic is due to the fact that the glycogen was hydrolyzed to 
glucose as outlined in the Materials and Methods section above. Significantly more glucose 
was released from cells treated with 10 nM Insulin and 10 nM Insulin + 10 µM RA (Figure 1). 
The trend of the graph showed that the control group had the lowest amount of glucose released, 
followed by the RA group, a sharp rise in the Ins and the RA + Ins groups. In Figure 1, the lack 
of additional significant increase in the amount of glucose present in the 10 nM Insulin + 10 µM 
RA group in comparison to the 10 nM Insulin group does not support the idea that the insulin 
synergized with RA to induce glycogenesis in HL1C hepatoma cells. 
 This experiment shows how the combination of insulin and RA can affect glucose stored 
as glycogen. From the data gathered and shown in Figure 1, it appears that RA alone is not 
sufficient for increasing the glycogen content in HL1C cells. Once in the presence of insulin, 
however, it is shown to significantly increase of the amount of glycogen.  
 The significance found within the insulin groups was to be expected. Insulin promotes 
glycogenesis to store the glucose as glycogen. This finding is significant to the health and 
physiology of an individual. The effects of 10nM Insulin and 10 µM RA seen in Figure 1 can be 
used to modify the diet in those suffering from glycogen storage diseases such as von Giereke’s 
Disease, Pompe’s disease, and McArdle’s disease 5. Supplementing the diet with vitamin A may 
not lead to a better storage of glucose as glycogen and decrease symptoms of certain diseases. 
Further research into this field will need to be conducted in order to identify more connections 
between vitamin A and glycogenesis to assist those suffering from glycogen storage diseases, 
diabetes, and other health problems.  
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These findings are important to all those with health problems relating to glucose 
metabolism, most notably those with diabetes. The lack of either insulin production in T1DM or 
the lack of the body’s response to the presence of insulin in T2DM indicates that the glucose will 
not be readily stored as glycogen under these diseases’ conditions. Management of the glucose 
metabolism is there for very important for individuals with both T1DM and T2DM. Consuming 
vitamin A with a meal has the potential to help with the control of glucose in the body. While not 
significant, the insulin + RA group also had a notably greater amount of glucose released 
compared to the RA group alone in HL1C cells. This shows that RA in the presence of insulin at 
least does not reduce the storage of glucose as glycogen.  
This experiment is one that needs further investigation. While similar studies have been 
conducted in muscle tissue, this is the first to investigate the role of RA on glycogenesis in 
hepatocytes. Upon further research and study, more information can be discovered to link 
vitamin A to the control of glycogenesis and glucose metabolism.  
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